What is the main business of Octapharma Poland?

The main business activity of Octapharma Poland focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on November 19, 2012.

Where is the headquarters located?

The headquarters is located at: ul. Jana Karola Chodkiewicza 8, 02-593 Warszawa.

What is the share capital?

The share capital of the company is PLN 1,276,000 (approx. $344,679).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

How much revenue was generated?

The company reported a revenue of $1,191,692 in 2025, which is a decrease of 1.5% compared to 2024.

Yes, in 2025 the company was profitable, achieving a net profit of $49,701, meaning the company increased its profit by 2.3%.

What is the main operating cost?

The largest operating cost category falls under employee remuneration. This category amounted to $519,599 in 2025, representing 46% of all operating expenses.

Octapharma Polandsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2012-11-19

Share capital

1,276,000.00 PLN

Activity description

Octapharma Poland is part of a global biopharmaceutical company that develops and manufactures plasma-derived and recombinant therapies. Its medicines are used in haematology, immunotherapy and critical care.

Registered address

ul. Jana Karola Chodkiewicza 8/U12, 02-593 Warszawa, Poland

Website

octapharma.com

Social media

Electronic delivery address

AE:PL-39949-90667-CAIJH-17

Financials

Revenue history (in k)

Financial insight

Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.

Filing timeliness

Financial statements were filed on time, on average 55 days early.

202517/04/2026
202411/06/2025
202321/05/2024
202226/06/2023
202127/06/2022
202025/06/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 1.19mMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD 49.70kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 1.13mMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 1.02mMedianUSD 609.79kAverageUSD 11.85m

Industry

Offer

Haematology medicines
Immunoglobulins
Critical care medicines
Pharmaceutical-grade excipients

Website technology

Website

Next.js

Authorized Representatives

Friedrich Cornelius Marguerre – Management Board Member

Jarosław Czarnota – Attorney-in-fact (sole)

Manner of representation

Two members of the management board acting jointly, or one member of the management board acting jointly with a commercial proxy, have the right to represent the company. In the case of one member being appointed to the management board, that member will have the right to represent the company independently.

Ownership

Owner	Shares	Share value	Stake
Octapharma Ag	12,760	$344,678.55	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2013-02-01.

mBank
63 1140 1977 0000 5629 4900 1001

Debt

No entries in the National Debtors Register (KRZ).

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
GWS Polandsp. z o.o.	$2,706,990.11	gwspoland.pl
Vente Amicalesp. z o.o.	$1,850,028.63	venteamicale.pl
Pube Globalsp. z o.o.	$1,777,827.09	pubeglobal.com
Atradis Polskasp. z o.o.	$1,284,064.17	atradis.pl
Celltrion Polandsp. z o.o.	$1,237,076.36	celltrion.pl
Ideal Polandsp. z o.o.	$1,092,652.45	ideal-poland.pl
Goodwill Pharma Polskasp. z o.o.	$664,724.30	goodwillpharma.com
Medis Polandsp. z o.o.	$487,846.47	medis.com
Unipharmsp. z o.o.	$404,433.20	unipharm.pl
Bonopharmsp. z o.o.	$405,123.74	bonopharm.com

Change history

Date	Event
2022-08-22	Address change (Domaniewska 39a, 02-672, Warszawa → Ul. Jana Karola Chodkiewicza 8/U12, 02-593, Warszawa)
2015-04-29	PKD change (Removed: 38 codes)
2013-03-05	Share capital increase (1,000,000.00 PLN → 1,276,000.00 PLN)
2012-11-19	Entered in the register

FAQ

Last updated: 2026-10-07